维普期刊资源整合服务平台（V6.5）

600篇 您的检索式：作者名="Kastratis"

选中清除导出查看参考文献查看引证文献引用追踪共30页首页上一页第1页下一页末页 /30 跳转

	题名	作者	年代	出处	被引量
1	14项比较西罗莫司洗脱支架和裸金属支架的临床试验的分析	Kastrati A. Mehilli J. Pache J. 黄浙勇	2007	世界核心医学期刊文摘(心脏病学分册)2007，0，8：	3
2	不同剂量(150mg/d与75mg/d)氯吡格雷治疗30d对患者血小板聚集的影响:随机、双盲研究显示文摘目的:探讨是否增加氯吡格雷维持剂量能增强对血小板聚集的抑制作用。方法和结果:60例经600mg氯吡格雷预治疗的患者在接受成功PCI术后12h内被纳入研究,以随机、双盲方式分为两组,分别接受氯吡格雷75mg/d或150mg/d治疗。PCI术后30d,分别采用光学聚集度测定和即时检测(VerifyNowTMP2Y12)方法测量血小板功能。	Von Beckerath N. Kastrati A. Wieczorek A. 吴超能	2007	世界核心医学期刊文摘(心脏病学分册)2007，，12：	2
3	A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel显示文摘	Kastrati A Mehilli J Schuhlen H	2004	N Engl J Med2004，350，：	1
4	Vessel size and long-term outcome after coronary stent placement显示文摘	Eleizi S Kastrati A Neumann F	1998	Circulation1998，98，18：	1
5	lntracoronary stentlng and angiographic results : strut thickness effect on restenosis outcome ( ISAR-STEREO-2 ) trial 显示文摘	Pache J Kastrati A MehiUi J	2003	J Am Coll Cardiol2003，41，8：	1
6	Clopido- grel therapy in patients undergoing coronary stenting:value of a high - loading - dose regimen 显示文摘	Pache J Kastrati A Mehilli J	2002	Catheter Cardiovasc Interv2002，55，：	1
7	Evaluation of prolonged antithrombotic pretreatment ( 'cooling-off' strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial 显示文摘	Neumann FJ Kastrati A Pogatsa-Murray G	2003	JAMA2003，290，：	1
8	The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders显示文摘	Bernlochner I Byrne RA Kastrati A	2011	Expert Rev Cardiovasc Ther2011，9，8：	1
9	Abeiximab and heparin versus bivalirudin for non-ST-elevation myocardial in-farction 显示文摘	Kastrati A Neumann F J Schulz S	2011	N Engl J Med2011，365，21：	1
10	Diabetes mellitus and the clinical and angiographic outcome after coronary stent piacement显示文摘	Elezi S Kastrati A Paehe J	1998	J AmColl Cardiol1998，32，7：	1
11	Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization显示文摘	Kandzari DE Berger PB Kastrati A	2004	J Am Coll Cardiol2004，44，：	1
12	Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction 显示文摘	Koch W Kastrati A Bottiger C	2001	Atherosclerosis2001，159，1：	1
13	Restenosis after coronary placement of various stent types显示文摘	Kastrati A Mehilli J Dirschinger J	2001	Am J Cardiol2001，87，1：	1
14	Circulating homoeysteine levels in patients with type 2 diabetes mellitus 显示文摘	Ndrepepa G Kastrati A Braun S	2008	Nutr Metab Cardiovasc Dis2008，68，2：	1
15	Randomized trial of a aonpolymer-based rapamycin-eluting stent versus a 3olymer-based paclitaxel-eluting stent for the reduction of late lumen loss显示文摘	JULINDA MEHILLI RAINER WESSELY et ADNAN KASTRATI al	2006	Circulation2006，113，：	1
16	Abciximab in patients with acute coronary syndromes undergoing pereutaneous coronary intervention after elopidogrel pretreatment : the ISAR-REACT 2 randomized trial 显示文摘	Kastrati A Mehilli J Neumann FJ	2006	JAMA2006，295，13：	1
17	PIA polymorphism of platelet glycoprotein Ⅲa and risk of restenosis after coronary stent placement显示文摘	Kastrati A Schomig A Sefarth M	1999	Circulation1999，99，：	1
18	Restenosis after coronary placement of various stent types显示文摘	Kastrati A Mehilli J Dirschinger J	2001	Am J Cardiol2001，87，：	1
19	Analysis of 14 trials comparing sirolimuseluting stents with bare-metal stents 显示文摘	Kastrati A Mehilli J Pache J	2007	N Engl J Med2007，356，：	1
20	Analysis of 14 trials comparing sirolimus- eluting stents with bare-metal stents显示文摘	Kastrati A Mehilli J Pache J	2007	N Engl J Med2007，356，：	1

返回顶部每页显示：

共30页首页上一页第1页下一页末页 /30 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示